PT74703B - Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine - Google Patents
Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amineInfo
- Publication number
- PT74703B PT74703B PT74703A PT7470382A PT74703B PT 74703 B PT74703 B PT 74703B PT 74703 A PT74703 A PT 74703A PT 7470382 A PT7470382 A PT 7470382A PT 74703 B PT74703 B PT 74703B
- Authority
- PT
- Portugal
- Prior art keywords
- naphtylmethyl
- inyl
- penetrable
- hept
- amongst
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2327/81A CH653256A5 (en) | 1981-04-06 | 1981-04-06 | Microemulsion for cutaneous use |
CH2631/81A CH647149A5 (en) | 1981-04-22 | 1981-04-22 | Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use |
CH327881 | 1981-05-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT74703A PT74703A (en) | 1982-05-01 |
PT74703B true PT74703B (en) | 1984-05-30 |
Family
ID=27173625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT74703A PT74703B (en) | 1981-04-06 | 1982-04-05 | Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine |
Country Status (16)
Country | Link |
---|---|
AU (1) | AU564570B2 (en) |
CA (1) | CA1192496A (en) |
DE (1) | DE3212053A1 (en) |
DK (1) | DK155882A (en) |
ES (1) | ES8308698A1 (en) |
FI (1) | FI821123L (en) |
FR (1) | FR2502951B1 (en) |
GB (2) | GB2098865B (en) |
GR (1) | GR75462B (en) |
IL (1) | IL65424A0 (en) |
IT (1) | IT8220611A0 (en) |
MY (1) | MY8600571A (en) |
NL (1) | NL8201413A (en) |
NZ (1) | NZ200232A (en) |
PT (1) | PT74703B (en) |
SE (1) | SE8202172L (en) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH655656B (en) * | 1982-10-07 | 1986-05-15 | ||
CA1225594A (en) * | 1983-05-20 | 1987-08-18 | Jourge Heller | Method for percutaneously administering physiologically active agents |
DE3406497A1 (en) * | 1984-02-23 | 1985-09-05 | Mueller Bernhard Willi Werner | HIGHLY DISPERSAL PHARMACEUTICAL MULTI-COMPONENT SYSTEMS AND METHOD FOR THEIR PRODUCTION |
JPH0667835B2 (en) * | 1984-03-01 | 1994-08-31 | サンド・アクチエンゲゼルシヤフト | Pharmaceutical composition |
US5364628A (en) * | 1985-05-31 | 1994-11-15 | Sandoz Ltd. | Pharmaceutical compositions |
US5639724A (en) * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
JPS61280426A (en) * | 1985-06-04 | 1986-12-11 | Ikeda Mohandou:Kk | Anti-inflammatory and analgesic application agent |
US4767625A (en) * | 1985-09-02 | 1988-08-30 | Kao Corporation | Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same |
US4690774A (en) | 1985-09-11 | 1987-09-01 | Chesebrough Pond's Inc. | Novel translucent water in oil emulsions |
US4797272A (en) * | 1985-11-15 | 1989-01-10 | Eli Lilly And Company | Water-in-oil microemulsions for cosmetic uses |
DE3805744C2 (en) * | 1987-03-04 | 1999-09-23 | Novartis Ag | Phenylcarbamate for the inhibition of acetylcholinesterase |
IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
US5342625A (en) * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
US7081445B2 (en) | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms |
DE3908047A1 (en) * | 1989-03-13 | 1990-09-20 | Desitin Arzneimittel Gmbh | HIGH DISPERSES PHARMACEUTICAL COMPOSITION |
US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
US5149719A (en) * | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
FR2673537B1 (en) * | 1991-03-08 | 1993-06-11 | Oreal | USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS. |
IE921212A1 (en) * | 1991-04-19 | 1992-10-21 | Affinity Biotech Inc | Convertible microemulsion formulations |
US5688761A (en) * | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
HU223343B1 (en) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Compositions comprising allylamine derivatives, and process for their preparation |
US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
GB9111611D0 (en) * | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
GB9126209D0 (en) * | 1991-12-10 | 1992-02-12 | Orion Yhtymae Oy | Drug formulations for parenteral use |
MX9207344A (en) * | 1991-12-16 | 1993-07-01 | Alza Corp | IMPROVED FORMULATIONS THAT HAVE HYDROPHOBIC IMPROVERS OF TRANSDERMIC PENETRATION AND METHOD TO PROVIDE IT. |
US5629019A (en) * | 1992-02-27 | 1997-05-13 | Alza Corporation | Formulations with hydrophobic permeation enhancers |
SG45449A1 (en) | 1992-05-13 | 1998-01-16 | Sandoz Ltd | Ophthalmic compositions |
DK0589843T3 (en) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporin-containing pharmaceutical preparations |
EP0671937A4 (en) * | 1992-10-16 | 1996-09-18 | Smithkline Beecham Corp | Pharmaceutical emulsion compositions. |
EP0684832A4 (en) * | 1993-02-17 | 1996-09-11 | Smithkline Beecham Corp | Microemulsions containing pharmaceutical compositions. |
DE59510233D1 (en) | 1994-11-03 | 2002-07-11 | Novartis Ag | NEW PREPARATION FORMS OF CYCLOSPORINE FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIOVAVAILABILITY AND METHOD FOR THE PRODUCTION THEREOF |
DE4442999A1 (en) | 1994-12-02 | 1996-06-05 | Hexal Pharma Gmbh | Pharmaceutical composition containing an active loratidine metabolite |
DE19549852B4 (en) | 1995-11-29 | 2009-06-04 | Novartis Ag | Cyclosporin containing preparations |
US5958876A (en) * | 1996-06-19 | 1999-09-28 | Novartis Ag | Cyclosporin-containing pharmaceutical compositions |
EP0988046B1 (en) | 1997-01-30 | 2004-09-15 | Novartis AG | Oil-free pharmaceutical compositions containing cyclosporin a |
US6346511B1 (en) | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin |
US6187747B1 (en) | 1997-09-08 | 2001-02-13 | Panacea Biotech Limited | Pharmaceutical composition comprising cyclosporin |
US6008191A (en) * | 1997-09-08 | 1999-12-28 | Panacea Biotec Limited | Pharmaceutical compositions containing cyclosporin |
IN188719B (en) * | 1997-09-08 | 2002-11-02 | Panacea Biotec Ltd | |
UY25225A1 (en) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS |
US6391282B1 (en) * | 1997-11-10 | 2002-05-21 | Flemington Pharmaceutical Corp. | Antihistamine sprays and ointments for relief of delayed contact dermatitis |
DE19825856A1 (en) * | 1998-06-10 | 1999-12-16 | Labtec Gmbh | New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion |
AU775523B2 (en) * | 1998-12-11 | 2004-08-05 | Pharmasolutions, Inc. | Self-emulsifying compositions for drugs poorly soluble in water |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
CA2529528A1 (en) * | 2003-06-20 | 2004-12-29 | Ronald Aung-Din | Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions |
US7112561B2 (en) | 2003-12-08 | 2006-09-26 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for insulin treatment |
US7740875B2 (en) | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US9308203B2 (en) * | 2008-10-01 | 2016-04-12 | Taiwan Biotech Co., Ltd. | Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (en) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | pharmaceutical composition of steroid hormone |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH570401A5 (en) * | 1972-05-09 | 1975-12-15 | Wander Ag Dr A | |
GB1559811A (en) * | 1975-07-28 | 1980-01-30 | Sandoz Ltd | Pharmaceutically active benzothiadiazole derivatives |
CH632268A5 (en) * | 1977-01-14 | 1982-09-30 | Sandoz Ag | Method for producing new heterocyclylaminoderivaten. |
-
1982
- 1982-03-30 FR FR8205611A patent/FR2502951B1/en not_active Expired
- 1982-03-31 FI FI821123A patent/FI821123L/en not_active Application Discontinuation
- 1982-04-01 DE DE19823212053 patent/DE3212053A1/en not_active Withdrawn
- 1982-04-02 NL NL8201413A patent/NL8201413A/en not_active Application Discontinuation
- 1982-04-02 GB GB8209940A patent/GB2098865B/en not_active Expired
- 1982-04-05 AU AU82334/82A patent/AU564570B2/en not_active Ceased
- 1982-04-05 CA CA000400470A patent/CA1192496A/en not_active Expired
- 1982-04-05 PT PT74703A patent/PT74703B/en unknown
- 1982-04-05 GR GR67821A patent/GR75462B/el unknown
- 1982-04-05 NZ NZ200232A patent/NZ200232A/en unknown
- 1982-04-05 DK DK155882A patent/DK155882A/en not_active IP Right Cessation
- 1982-04-05 IL IL65424A patent/IL65424A0/en unknown
- 1982-04-05 ES ES511169A patent/ES8308698A1/en not_active Expired
- 1982-04-06 IT IT8220611A patent/IT8220611A0/en unknown
- 1982-09-10 SE SE8202172A patent/SE8202172L/en not_active Application Discontinuation
-
1984
- 1984-04-04 GB GB08408654A patent/GB2148711B/en not_active Expired
-
1986
- 1986-12-30 MY MY571/86A patent/MY8600571A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB2098865A (en) | 1982-12-01 |
FI821123A0 (en) | 1982-03-31 |
DK155882A (en) | 1982-12-10 |
GB2098865B (en) | 1985-12-18 |
ES511169A0 (en) | 1983-10-01 |
FR2502951A1 (en) | 1982-10-08 |
MY8600571A (en) | 1986-12-31 |
AU8233482A (en) | 1982-10-14 |
NZ200232A (en) | 1985-08-16 |
AU564570B2 (en) | 1987-08-20 |
CA1192496A (en) | 1985-08-27 |
GB2148711B (en) | 1985-12-18 |
PT74703A (en) | 1982-05-01 |
GR75462B (en) | 1984-07-20 |
ES8308698A1 (en) | 1983-10-01 |
IL65424A0 (en) | 1982-07-30 |
NL8201413A (en) | 1982-11-01 |
GB8408654D0 (en) | 1984-05-16 |
FR2502951B1 (en) | 1985-12-06 |
IT8220611A0 (en) | 1982-04-06 |
DE3212053A1 (en) | 1982-10-21 |
SE8202172L (en) | 1982-10-07 |
GB2148711A (en) | 1985-06-05 |
FI821123L (en) | 1982-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT74703B (en) | Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine | |
HU188768B (en) | Fungicides, insecticides and acaricides,as well as process for the preparation of their amino-pyrimidine derivatives active ingredients | |
DE3067390D1 (en) | Sulfonyl ureas, processes for their preparation and pharmaceutical compositions containing these compounds | |
DE2961289D1 (en) | Pyrimidones, processes for their preparation and pharmaceutical compositions containing them | |
HUT53873A (en) | Insecticides comprising nitro compounds as active ingredient and process for producing the active ingredients | |
DE3069559D1 (en) | Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use | |
DE2861289D1 (en) | Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds | |
DE3061586D1 (en) | Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them | |
DE2964819D1 (en) | Platinum complexes, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments | |
DE2963061D1 (en) | Hydantoin compounds, their preparation and pharmaceutical formulations containing them | |
IL59425A (en) | Pharmaceutical compositions comprising n-substituted aziridine-2-carboxylic acid derivatives,certain such compounds and their preparation | |
DE3261497D1 (en) | Substituted n-(4-indolyl-piperidino-alkyl) benzimidazolones, processes for their preparation and their use as pharmaceutical preparations | |
DE3266360D1 (en) | Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation | |
EP0098121A3 (en) | Platinum complexes, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments | |
IL61207A0 (en) | Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation | |
JPS55111494A (en) | Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient | |
IL54468A0 (en) | Process for the preparation of urea derivatives, urea derivatives obtained thereby and herbicide formulations comprising or containing said derivatives | |
IL57599A0 (en) | Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation | |
HUT46660A (en) | Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient | |
IL59804A (en) | Peptides having thymopoietin-like activity,their preparation and pharmaceutical compositions containing them | |
HUT44909A (en) | Herbicides comprising 1-aryl-4-substituted-1,4-dihydro-5h-tetrazol-5-one derivatives and their sulphur analogs as active ingredient and process for producing the active ingredients and intermediaries thereof | |
ZA793131B (en) | Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation | |
ZA801846B (en) | N,n-dimethyl-carbamic acid o-pyrazolyl esters,processes for their preparation and their use as agent for combating pests | |
ZA794623B (en) | N,n-dimethyl-carbamic acid o-pyrimidinyl esters,processes for their preparation and their use as agents for combating pests | |
IL55427A0 (en) | 2-hydrazonopropionic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |